Behavioral sensitization, defined as a progressive increase in the locomotor stimulant effects elicited by repeated exposure to drugs of abuse, has been used as an animal model for drug craving in humans. The mesoaccumbens dopaminergic system has been proposed to be critically involved in this phenomenon; however, few studies have been designed to systematically investigate the effects of dopaminergic antagonists on development and expression of behavioral sensitization to ethanol in Swiss mice. We first tested the effects of D 1 antagonist SCH-23390 (0-0.03 mg/kg) or D 2 antagonist Sulpiride (0-30 mg/kg) on the locomotor responses to an acute injection of ethanol (2.0 g/kg). Results showed that all tested doses of the antagonists were effective in blocking ethanol's stimulant effects. In another set of experiments, mice were pretreated intraperitoneally with SCH-23390 (0.01 mg/kg) or Sulpiride (10 mg/kg) 30 min before saline or ethanol injection, for 21 days. Locomotor activity was measured weekly for 20 min. Four days following this pretreatment, all mice were challenged with ethanol. Both antagonists attenuated the development of ethanol sensitization, but only SCH-23390 blocked the expression of ethanol sensitization according to this protocol. When we tested a single dose (30 min before tests) of either antagonist in mice treated chronically with ethanol, both antagonists attenuated ethanol-induced effects. The present findings demonstrate that the concomitant administration of ethanol with D 1 but not D 2 antagonist prevented the expression of ethanol sensitization, suggesting that the neuroadaptations underlying ethanol behavioral sensitization depend preferentially on D 1 receptor actions.
Introduction
Behavioral sensitization is defined as a progressive enhancement in the behavioral responses following repeated administration of psychostimulants, opioids, ethanol and other drugs (Camarini et al., 1995 (Camarini et al., , 2008 Masur and Boerngen, 1980; Shuster et al., 1975 Shuster et al., , 1977 Wallach and Gershon, 1971) .
Sensitization is a long-lasting phenomenon accompanied by cellular neuroadaptations that likely contribute to addictive behavior. For this reason, it has been considered a useful animal model of drug addiction.
Particularly for ethanol, behavioral sensitization has been linked to uncontrolled intake of the substance of abuse (Hunt and Lands, 1992) , although the relationship between ethanol-induced sensitization and ethanol intake is still uncertain. For instance, Frozino-Ribeiro et al. (2008) found no difference in terms of ethanol-induced sensitization among heavy and light drinker mice. Conversely, Borges et al. (2006) found that mice classified as "high-sensitized" or "non-sensitized" drank roughly the same amounts of ethanol. Ethanol sensitization is observed especially following repeated administration of low doses of the drug, since high doses induce tolerance rather than sensitization (Masur and Boerngen, 1980) . Although many neurotransmitter systems have been implicated in several behavioral effects of ethanol, the acute stimulant effects of this drug involve mainly dopaminergic systems (Arias et al., 2010; Broadbent et al., 1995; Cohen et al., 1997; Liljequist et al., 1981; Pastor et al., 2005; Phillips and Shen, 1996) . Both acute and repeated administration of ethanol is well known to increase dopaminergic neurotransmission in the mesolimbic system (Di Chiara and Imperato, 1985; Nestby et al., 1997) accounting, at least in part, for the reinforcing effects of this drug.
A number of neurochemical studies have focused on the mechanisms responsible for behavioral sensitization to ethanol (Bellot et al., 1996; Broadbent et al., 1995 Broadbent et al., , 2005 Broadbent and Harless, 1999; Camarini et al., 2000a,b; de Araujo et al., 2009; Gevaerd and Takahashi, 1999; Itzhak and Martin, 2000; Phillips and Shen, 1996; Quadros et al., 2002; Souza-Formigoni et al., 1999; ) . However, Pharmacology, Biochemistry and Behavior 98 (2011) 173-180 few studies have examined the involvement of dopaminergic antagonists in behavioral sensitization to ethanol (Broadbent et al., 1995 (Broadbent et al., , 2005 Gevaerd and Takahashi, 1999) , despite the prevalence of alcoholism and the necessity of finding new treatment targets for the development of novel pharmacological interventions for this condition.
In a recent overview of the incentive sensitization theory of addiction, Robinson and Berridge (2008) reaffirmed that drugs of abuse share the ability to sensitize a common neural system, the mesotelencephalic dopaminergic system, which sends projections from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) and medial prefrontal cortex (mPFC). This system has been extensively studied as a possible mediator of behavioral sensitization.
Repeated administration of psychostimulant drugs is supposed to cause a long-lasting supersensitivity of postsynaptic D 1 receptors in the NAc, dopamine (DA) autoreceptor subsensitivity in the VTA and enhancement of the DA release in the NAc (Henry and White, 1991; Robinson et al., 1988; White and Wang, 1984) . These functional changes in the mesolimbic dopaminergic system have been found to accompany behavioral sensitization. Moreover, it has been suggested that the VTA is the site involved in the transient neuroadaptations that occur during the development of this phenomenon, while the NAc and mPFC have important roles in the persistent neuronal changes underlying the expression of behavioral sensitization (for reviews, see Pierce and Kalivas, 1997; Vanderschuren and Kalivas, 2000) . These and other neurochemical observations subjacent to sensitization have led to pharmacological studies showing the efficacy of DA antagonists in blocking behavioral sensitization to psychostimulant drugs (Hamamura et al., 1991; Kuribara and Uchihashi, 1994; Reimer and Martin-Iverson, 1994; Vezina and Stewart, 1989) .
While the contribution of dopaminergic receptor subtypes in ethanol-stimulated activity is well recognized, the extent to which DA receptors are involved in mediating the development and expression of sensitization to ethanol is not clear. Understanding the mechanisms involved in sensitization to ethanol may contribute toward understanding alcohol addiction and provide a foundation for further pharmacotherapeutic strategies.
Hence, the objectives of this study were to investigate the effects of D 1 (SCH-23390) and D 2 (Sulpiride) dopaminergic receptor antagonists on the locomotor responses to acute ethanol and the effects of these antagonists on the development and expression of behavioral sensitization to ethanol.
Material and methods

Subjects
Three-month old Swiss male mice obtained from the UNIFESP colony were housed in polypropylene cages (32 × 40 × 15 cm) in groups of 10 or 15 per cage, with free access to food and water. The colony room was maintained on a 12-h light-dark cycle (with lights on at 7:00 AM) under controlled temperature. The experimental procedures were carried out in accordance with the "International Guiding Principles for Biomedical Research Involving Animals" (Council of International Organization of Medical Sciences, Geneva, 1985) .
Apparatus
The spontaneous locomotor activity of each animal was measured in an open-field arena (40 cm in diameter) surrounded by a 50 cmhigh wall. A video camera installed 230 cm above the apparatus was connected to a computer located outside of the experimental chamber. Camera images were sent to the computer and horizontal locomotion was quantified by EthoVision software (Noldus Information Technology, The Netherlands) over the course of 20 min after ethanol or saline injections.
Ethanol solution and drugs
Ethanol (Merck do Brasil S.A., Brazil) was administered as a 15% v/v solution, diluted with 0.9% saline, at a dose of 2.0 g/kg intraperitoneally (i.p.). The dose was chosen based on previous published studies from our laboratory (Camarini et al., 1995; Bellot et al., 1996; Camarini et al., 2000a,b; Camarini and Hodge, 2004; Araujo et al., 2005; Faria et al., 2008) .
The D 1 receptor antagonist SCH-23390 (Schering-Plough S.A., Brazil) was dissolved in saline and injected i.p. The D 2 receptor antagonist Sulpiride (Sigma-Aldrich Brasil Ltda., Brazil) was first dissolved in one drop of 1% glacial acetic acid and then the solution was diluted with saline; Sulpiride was administered i.p. The injection volume for SCH-23390 and Sulpiride was held at 0.1 mL/10 g. Doses and route of administration were chosen according to previously published studies (Cohen et al., 1997; Kuribara and Uchihashi, 1994; Kuribara, 1995; Lê et al., 1997; Pastor et al., 2005) . The doses chosen for the chronic experiments were also based on the results from Experiment 1, which were the intermediate doses without effect on the activity in control animals.
Experimental procedures
The experiments were always conducted between 10:00 AM and 1:00 PM, approximately. In all experiments, mice were habituated in the open-field on 2 days before starting the experiments, although the data for the habituation sessions are not shown with the main data for Experiment 1 to avoid an excess of information in the figure. Two days before initiating the experiment, mice were randomly assigned to the groups and each animal received a saline injection for the recording of locomotor activity over a period of 20 min. These days were denominated "Habituation Days" and were designed to minimize habituation across trials. Furthermore, this procedure was intended to avoid a possible increase in DA activity induced by novelty (Legault and Wise, 2001) .
To examine the effects of the DA antagonists on the development of behavioral sensitization to ethanol, mice were randomly assigned to one of four groups: Saline/Saline (S/S), Saline/Ethanol (S/E), Antagonist/Saline (A/S), and Antagonist/Ethanol (A/E). Each mouse was first injected daily with saline or the antagonist (0.01 mg/kg SCH-23390 or 10 mg/kg Sulpiride), 30 min prior to an injection of saline or 2.0 g/kg ethanol, for 21 days. Mice received the injections in the environment where they were tested and were then returned to their colony room. The locomotor activity was recorded for 20 min weekly, i.e., on treatment days 1, 7, 14 and 21, immediately after the second injection. Mice received no treatment from days 22 to 24. DA antagonists were removed 96 h before the test day to prevent any residual effect of these drugs on the behavioral sensitization to ethanol. On day 25, all mice were challenged with ethanol (2.0 g/kg) and their locomotor activity was measured over 20 min. Each D 1 /D 2 drug dose was tested in a separate group of mice.
2.4.3. Experiment 3: effects of single dose of D 1 or D 2 receptor antagonists on the expression of sensitization to the stimulant effect of ethanol Initially, mice were injected daily with either saline or ethanol (2.0 g/kg) over a period of 21 days. Following ethanol sensitization and a 96-h drug-free interval, ethanol-pretreated and saline-pretreated mice were randomly sub-divided into 2 groups, which received saline or SCH-23390 (0.01 mg/kg) 30 min prior to an ethanol challenge injection (2.0 g/kg). The locomotor activity was assessed for 20 min immediately after the test injection.
The experimental design for Sulpiride (10 mg/kg) was the same as that used for SCH-23390.
Experiment 4: blood ethanol concentration (BEC)
Separate experiments were conducted to determine BEC using identical procedures to those described in Experiments 2 and 3. Mice were sacrificed by cervical dislocation at 20 min after the last ethanol injection to assess possible effects of dopamine antagonists on the pharmacokinetics of ethanol. The 20-min time point was chosen because it corresponds to the end of the locomotor behavior test but still falls within the peak of the locomotor stimulant effect of ethanol (Meyer and Phillips, 2007) .
Blood ethanol concentrations were determined according to a modified method previously published (for details, see Yonamine et al., 2003) . Hamilton air-tight syringe was used to extract 0.25 mL vapor aliquot (headspace procedure) prior to the gas chromatograph run (6890, Agilent, Palo Alto, CA, USA) with a flame ionization detector (GC-FID). The oven temperature was isothermal at 130°C and the injector port and detector were set at 250°C. Separations were performed on a Poraplot Q fused-silica capillary column (10 m × 0.32 mm; Varia, Midelburg, Netherlands). The retention times for ethanol and n-butanol were 4.2 and 9.2 min, respectively.
Statistical analysis
All data are expressed as mean ± S.E.M. Statistical comparisons were made by analysis of variance (ANOVA) or repeated measures (RM) ANOVA (for within-group comparisons), followed by post-hoc Newman-Keuls tests (Statistica, StatSoft, Tulsa, OK, USA). In Experiments 1, 2 and 3 locomotor activity during habituation trials was analyzed through RM-ANOVAs, with days as repeated measures. In Experiment 1, the experimental design was a 2 (Saline or Ethanol) × 5 (Saline or DA antagonist doses) between groups factorial. In Experiment 2, the experimental design was a 2 (Saline or DA antagonist) × 2 (Saline or Ethanol) × 4 (Days) factorial with days as a within-subjects factor. The data from the ethanol challenge day were analyzed through a 2 (Saline or DA antagonist) × 2 (Saline or Ethanol). A t-test for independent measures was used to compare the increase in locomotor activity between two groups. Whenever necessary, the loci of significant main effects or interactions were further examined through follow-up ANOVAs. In Experiment 3, the experimental design was a 2 (Saline or Ethanol) × 2 (Saline or DA antagonist) between groups factorial. In Experiment 4, BEC was analyzed through a 2 (Saline or DA antagonist) × 2 (Saline or Ethanol) factorial. The level of significance was set at p b 0.05. , respectively. The means ± SEM for SCH-23390 saline group in habituation days 1 and 2 were respectively: 3442.6 ± 90.1 and 2246.5 ± 78.6 cm and for SCH-23390 ethanol group in habituation days 1 and 2 were respectively: 3426.5 ± 91.4 and 2101.5 ± 83.6 cm. The means ± SEM for Sulpiride saline group in habituation days 1 and 2 were respectively: 2999.3 ± 112.6 and 2116.6 ± 76.8 cm and for Sulpiride ethanol group in habituation days 1 and 2 were respectively: 2941.7 ± 95.7 and 2116.6 ± 75.4 cm.
The effects of different doses of SCH-23390 or Sulpiride on ethanol-induced locomotor activation are shown in Fig. 1 (panels A  and B) . The number of mice for each group was 10. A two-way ANOVA revealed a main effect of SCH-23390 [F(6,126 A two-way ANOVA revealed a main effect of Sulpiride [F(6,126 Although all doses of Sulpiride reduced the ethanol-induced locomotor stimulation, the doses of 5, 10 and 15 mg/kg decreased the locomotion to levels similar to those of the saline group. The highest dose (30 mg/ kg) affected also activity levels in saline-treated mice. S a li n e /E th a n o l A n ta g o n is t/ S a li n e A n ta g o n is t/ E th a n o l S a li n e /S a li n e S a li n e /E th a n o l A n ta g o n is t/ S a li n e A n ta g o n is t/ E th a n o l SCH-23390 reduced the locomotor activity in both acute and repeated ethanol-treated mice (Fig. 3A) .
The same statistical analysis was applied to the Sulpiride data and also revealed a locomotor-stimulant effect of Ethanol [F(1,40 Sulpiride also reduced the locomotor activity in both acute and repeated ethanol-treated mice (Fig. 3B) .
Experiment 4: blood ethanol concentration (BEC)
Data of the BECs of the groups from Experiment 2 are shown in Table 1 .
Analysis of the BECs from the four groups (Saline/Saline; Saline/ Ethanol; SCH-23390/Saline, SCH-23390/Ethanol) after an ethanol challenge (Experiment 2), showed no effect of SCH-23390 or ethanol and no interaction between these two factors { [F(1,28) Data of the BECs of the groups from Experiment 3 are shown in Table 1 . ANOVA showed no effect of ethanol or SCH-23390 and no interaction between these two factors {[F(1,28) = 1. 
Discussion
The present study shows the effects of D 1 (SCH-23390) and D 2 (Sulpiride) antagonists on the development and expression of sensitization to ethanol as well as on the stimulant effect of a single injection of ethanol at 2.0 g/kg.
Our results confirmed the previously reported stimulant effect of ethanol at a dose of 2.0 g/kg in Swiss mice (Camarini et al., 1995 (Camarini et al., , 2000a Masur and Boerngen, 1980) and also the reliable attenuating effects of SCH-23390 or Sulpiride on the locomotor-activating effects of ethanol (Arias et al., 2010; Cohen et al., 1997; Liljequist et al., 1981; Pastor et al., 2005; Phillips and Shen, 1996) . However, there have also been reports of a lack of effect in mice (Boyce and Risinger, 2002; Gevaerd and Takahashi, 1999; Pastor et al., 2005; Scibelli and Phillips, 2009 ). This discrepancy in the literature may be explained by the fact that neurochemical mediators responsible for the ethanol-induced stimulation vary as a function of species, strain, dose, time of measurement of locomotor activity and also novelty to test procedure. Indeed, in the study by Pastor et al. (2005) Sulpiride blocked ethanolinduced stimulation only in mice not previously habituated to the test environment. Consequently, all these factors should be carefully considered in future studies.
The stimulant effects of ethanol are known to be mediated by the mesolimbic dopaminergic system through an increase in DA release in the NAc (Di Chiara and Imperato, 1985) and it is expected that DA receptors have an important role in the mechanisms underlying this effect. On the other hand, ethanol's dose-dependent effects involve several different neurotransmitters in the brain. It is well known that low doses of ethanol stimulate dopaminergic activity and reduce GABA turnover (Di Chiara and Imperato, 1985; Hunt and Majchrowicz, 1983) . Ethanol facilitates DA release in the NAc by enhancing the firing rate of dopaminergic neurons in the VTA (Bunney et al., 2001; Gessa et al., 1985) . It is hypothesized that this effect is mediated by ethanol stimulation of GABA A receptors in the VTA and that the blockade of D 1 receptors by SCH-23390 influences the response of GABA neurotransmission to ethanol on dopaminergic neurons. In fact, neuropharmacological manipulations with GABA B agonists (Quintanilla et al., 2008; Shen et al., 1998) or opioid antagonists (Camarini et al., 2000b; Pastor and Aragon, 2006) inhibit ethanol-induced stimulation, probably through an action upon dopaminergic neurons (Arias et al., 2009 ).
In the present study, blockade of D 2 receptors also reduced ethanol-induced stimulation, which is an interesting finding because the role of D 2 receptors in the locomotor-stimulating effects of ethanol has been debated. Although our results are in agreement with other reports (Cohen et al., 1997; Koechling and Amit, 1993) , an elegant study by Pastor et al. (2005) showed that ethanol-induced stimulation can occur independently of D 2 receptors once the animals have been habituated to the environment. A possible explanation for the differences between our results and those of Pastor et al. is the higher number of habituation sessions in their study.
One striking result of this study is the up-regulation of D 1 receptors suggested by the increase in the locomotor activity of saline-treated mice following repeated daily injections of D 1 antagonist. Since the locomotor activity of mice treated with the combination of SCH-23390 and ethanol also increased across treatment days it is likely that the increased density of D 1 receptors caused the ethanol stimulant effect to emerge, although at a lower magnitude than that in the group treated with ethanol without the antagonist. More to the point, co-administration of D 1 antagonist with ethanol did not result in locomotor sensitization following 96 h of antagonist withdrawal, showing that the D 1 antagonist attenuated the development of ethanol sensitization and blocked the expression of this phenomenon.
Studies with radioligand binding assays have demonstrated a selective increase in D 1 receptors after chronic treatment with SCH-23390 (Giorgi et al., 1993; Hess et al., 1988) . In the present investigation this effect was manifested through an increase in locomotor activity, as has been previously demonstrated in rats (Maldonado et al., 1990) , probably in response to endogenous DA, what may be a result of some degree of stress or novelty. Following 96 h of antagonist withdrawal, the dopaminergic supersensitivity was normalized, since we found similar activity levels in the group treated repeatedly with SCH-23390 and the saline control group, after a challenge injection of ethanol. Thus, we assumed that there was no residual effect of SCH-23390 on the challenge day.
By contrast with the D 1 antagonist results, repeated Sulpiride treatment did not prevent the expression of behavioral sensitization to ethanol, albeit attenuating both the stimulant effect of ethanol and the development of ethanol sensitization (Experiment 2). Although an acute Sulpiride injection reduced the activity of mice chronically treated with ethanol (Experiment 3), this result seems to reflect a potent depressant effect of Sulpiride over ethanol-induced stimulation rather than an effect on the neuroadaptations underlying sensitization. Taken together, these pieces of evidence regarding the blockade of ethanol-induced stimulation appear not to imply the inhibition of expression of sensitization, indicating that ethanol's stimulant effect and the expression of ethanol sensitization occur through different neuronal mechanisms, as has been previously suggested (Broadbent et al., 1995; Phillips et al., 1995) . In fact, although a negative correlation between D 2 binding and the ethanol stimulant response has been described, no association was found between D 2 binding and sensitization to ethanol in the shell of the NAc in mice (Hitzemann et al., 2003; Phillips et al., 1995) . Broadbent et al. (1995) used haloperidol as a D 2 receptor blocker and reported that this drug was able to abolish the acute locomotor responses to ethanol, but failed to prevent the development of sensitization, which is in agreement with the results of the present study using a more selective D 2 antagonist. In a similar context, haloperidol produced a dose-dependent decrease in ethanol-induced locomotor activity, but did not affect ethanol-induced conditioned place preference Risinger et al., 1992) , which reinforces the hypothesis of differential effects of D 2 antagonism across different models for assessing ethanol's hedonic effects. Although our findings and the study by Broadbent et al. (1995) obtained similar results, additional research will be required to elucidate the role of D 2 sensitization in the development of sensitization to ethanol. These findings appear to reduce the importance of D 2 receptors in the BEC data (expressed in g/L) are shown as mean ± SEM of each treatment group (n = 8 per group). The experiments were the same as described in Figs. 2 and 3 (Experiments 2 and 3, respectively). In Experiment 2, blood ethanol levels were similar in all groups (Saline/Saline; Saline/Ethanol; Antagonist/Saline; Antagonist/Ethanol) at 20 min after ethanol challenge. In Experiment 3, no differences were found among groups (Saline-Saline/Ethanol; Ethanol-Saline/Ethanol; Saline-Antagonist/Ethanol; Ethanol-Antagonist/Ethanol). Two-way ANOVA followed by post-hoc Newman-Keuls. Araujo et al., 2009; Souza-Formigoni et al., 1999) . The present results also demonstrated that repeated administration of Sulpiride progressively decreased the locomotor activity of mice throughout the treatment as compared to day 1 (Experiment 1). In previous work Sulpiride was found to induce supersensitivity of D 2 receptors since withdrawal from long-term Sulpiride administration increased the locomotor activity in rats (Frussa-Filho and Palermo-Neto, 1990) . However, this effect appears to be dependent on the dose, since striatal D 2 receptor desensitization has already been reported after repeated administration of low doses of Sulpiride, due to preferential blockade of D 2 autoreceptors and a consequent increase in DA release (Sigala et al., 1991) . This effect is supposed to reduce the sensitivity to drugs of abuse, which has been described, for example, by Kuribara (1996) , who demonstrated that Sulpiride inhibited methamphetamine sensitization at low doses, but not at high doses. Conversely, at high doses Sulpiride produced supersensitivity of D 2 receptors and increased the sensitivity to the psychostimulant drug (Kuribara, 1996) . Thus, dopaminergic inhibitory modulation acting through D 2 receptors may exert a differential influence upon the neural mechanisms involved in the drug-stimulant effects and locomotor behavioral sensitization. It has been shown, for example, that Sulpiride i.p. has no effect upon cocaine or apomorphine-induced sensitization (Mattingly et al., 1991 (Mattingly et al., , 1994 , while infusion of Sulpiride into the mPFC enhances the locomotor-stimulant effect of cocaine (Steketee, 2005) .
Using an experimental design similar to those of several other studies (Camarini et al., 2000a,b; Harrison and Nobrega, 2009; Heidbreder et al., 1996; Martin-Iverson and Reimer, 1994; Tella, 1994) , we found that an acute injection of either D 1 or D 2 antagonists attenuated the expression of sensitization in ethanol-sensitized mice. An issue of some concern in the interpretation of these results was the observation that D 1 and D 2 antagonists have a depressant effect upon ethanol-induced stimulation and, thus, it would not be clear whether the antagonists were blocking ethanol's acute effects or disrupting the neural mechanisms of ethanol sensitization. Indeed, D 2 blockade did not block the expression of ethanol sensitization once it had been induced.
In conclusion, we can suggest that D 2 blockade reduces the acute locomotor stimulant effect of ethanol but does not interfere with the long-term neuroadaptive changes underlying the expression of ethanol sensitization. The current study supports other reports (Broadbent et al., 1995; Phillips et al., 1995) of a dissociation between the mechanisms underlying the stimulant effects of ethanol and behavioral sensitization. Furthermore, we extend this finding to suggest that D 1 receptors, in particular, are an important component of the neural substrates that provide the basis for the development and expression of behavioral sensitization to ethanol.
